ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02136134
Brief Title: Addition of Daratumumab to Combination of Bortezomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma

First Submitted : May 1, 2014
First Submitted that Met QC Criteria : May 8, 2014
First Posted : May 12, 2014 (Estimate)

Results First Submitted : December 20, 2016
Results First Submitted that Met QC Criteria : December 20, 2016
Results First Posted : February 10, 2017

Last Update Submitted that Met QC Criteria : May 31, 2018
Last Update Posted : June 1, 2018